Search

everythinglearnresearchcommunity

for

Search:↓

Cosmerna ARI effectively reduces hair loss and increases hair density in Europeans with androgenetic alopecia.

FOXC1 boosts SFRP1 in hair loss, suggesting new treatments.

A woman had an unusual allergic reaction to a hair loss treatment, which cleared up after stopping the treatment and using a different medication.

Diffuse telogen alopecia is temporary hair loss treated by addressing the root cause and improving scalp health.

Green tea component EGCG may help prevent hair loss by changing microRNA levels in certain scalp cells.

Genomic approach finds new possible treatments for hair loss.

Removing a specific gene in certain skin cells causes hair loss on the body by disrupting normal hair development.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Researchers identified genes in scalp hair follicles that may affect hair traits and hair loss.

Pharmacists play a key role in health education and managing treatments for conditions like hair loss and smoking cessation.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

H19 boosts hair growth potential by activating Wnt signaling, possibly helping treat hair loss.

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Botulinum toxin type A helps treat hair loss by stopping cell death in hair follicles through a process involving certain non-coding RNAs and a protein called Bax.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Deleting MED1 in skin cells causes hair loss and skin changes.

Silencing NtNCED3-2 gene in tobacco reduces drought tolerance and impairs growth.

The new microneedle method delivers hair loss treatment more effectively by enhancing growth pathways.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Some natural compounds can protect fish ear cells from damage by certain antibiotics without affecting the antibiotics' ability to fight infections.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

Escin may help treat hair loss by boosting a specific cell growth pathway.